Drug Shortage Report for SHINGRIX
| Report ID | 45716 |
| Drug Identification Number | 02468425 |
| Brand name | SHINGRIX |
| Common or Proper name | Herpes Zoster vaccine |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN |
| Strength(s) | 50MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1's |
| ATC code | J07BK |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-04-30 |
| Estimated end date | 2018-06-15 |
| Actual end date | 2018-06-06 |
| Shortage status | Resolved |
| Updated date | 2018-06-08 |
| Company comments | Most recent supply released May 15, 2018 with limited quantity. SHINGRIX is available in packages of 10. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-04-13 | English | Compare |
| v2 | 2018-04-13 | French | Compare |
| v3 | 2018-05-02 | English | Compare |
| v4 | 2018-05-02 | French | Compare |
| v5 | 2018-05-17 | English | Compare |
| v6 | 2018-05-17 | French | Compare |
| v7 | 2018-06-08 | English | Compare |
| v8 | 2018-06-08 | French | Compare |
Showing 1 to 8 of 8